Southwick F (10. prosinca 2007.). „poglavlje 4: Pulmonary Infections”. Infectious Diseases: A Clinical Short Course, 2. izdanje. McGraw-Hill Medical Publishing Division. str. str. 104.. ISBN0-07-147722-5. Arhivirano iz originala na datum 2012-07-13. Pristupljeno 2013-08-11.
Madison B (2001). „Application of stains in clinical microbiology”. Biotech Histochemsvezak 76 (broj 3): str. 119.–125.. DOI:10.1080/714028138. PMID11475314.
Parish T, Stoker N (1999). „Mycobacteria: bugs and bugbears (two steps forward and one step back)”. Molecular Biotechnologysvezak 13 (broj 3): str. 191.–200.. DOI:10.1385/MB:13:3:191. PMID10934532.
van Soolingen D i dr.. (1997). „A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa”. International Journal of Systematic Bacteriologysvezak 47 (broj 4): str. 1236.–1245.. DOI:10.1099/00207713-47-4-1236. PMID9336935.
Thoen C, Lobue P, de Kantor I (2006). „The importance ofMycobacterium bovis as a zoonosis”. Vet. Microbiol.svezak 112 (broj 2–4): str. 339.–345.. DOI:10.1016/j.vetmic.2005.11.047. PMID16387455.
Chaisson, RE; Martinson, NA (2008-03-13). „Tuberculosis in Africa--combating an HIV-driven crisis”. The New England Journal of Medicinesvezak 358 (11): str. 1089.–1092.. DOI:10.1056/NEJMp0800809. PMID18337598.
Griffith D, Kerr C (1996). „Tuberculosis: disease of the past, disease of the present”. J Perianesth Nurssvezak 11 (broj 4): str. 240.–245.. DOI:10.1016/S1089-9472(96)80023-2. PMID8964016.
Möller, M; Hoal, EG (2010). „Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis”. Tuberculosis (Edinburgh, Scotland)svezak 90 (broj 2): str. 71.–83.. DOI:10.1016/j.tube.2010.02.002. PMID20206579.
Cole E, Cook C (1998). „Characterization of infectious aerosols in health care facilities: an aid to effective engineering controls and preventive strategies”. Am J Infect Controlsvezak 26 (broj 4): str. 453.–464.. DOI:10.1016/S0196-6553(98)70046-X. PMID9721404.
Nicas M, Nazaroff WW, Hubbard A (2005). „Toward understanding the risk of secondary airborne infection: emission of respirable pathogens”. J Occup Environ Hygsvezak 2 (broj 3): str. 143.–154.. DOI:10.1080/15459620590918466. PMID15764538.
Ahmed N, Hasnain S (2011). „Molecular epidemiology of tuberculosis in India: Moving forward with a systems biology approach”. Tuberculosissvezak 91 (broj 5): str. 407.–413.. DOI:10.1016/j.tube.2011.03.006. PMID21514230.
Houben E, Nguyen L, Pieters J (2006). „Interaction of pathogenic mycobacteria with the host immune system”. Curr Opin Microbiolsvezak 9 (broj 1): 76–85. DOI:10.1016/j.mib.2005.12.014. PMID16406837.
Herrmann J, Lagrange P (2005). „Dendritic cells and Mycobacterium tuberculosis: which is the Trojan horse?”. Pathol Biol (Paris)svezak 53 (broj 1): str. 35.–40.. DOI:10.1016/j.patbio.2004.01.004. PMID15620608.
Rothel J, Andersen P (2005). „Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent?”. Expert Rev Anti Infect Thersvezak 3 (broj 6): str. 981.–993.. DOI:10.1586/14787210.3.6.981. PMID16307510.
Wang, JY; Lee, LN, Lai, HC, Hsu, HL, Liaw, YS, Hsueh, PR, Yang, PC (2007-06-15). „Prediction of the tuberculosis reinfection proportion from the local incidence”. The Journal of infectious diseasessvezak 196 (broj 2): str. 281.–288.. DOI:10.1086/518898. PMID17570116.
Pearce-Duvet J (2006). „The origin of human pathogens: evaluating the role of agriculture and domestic animals in the evolution of human disease”. Biol Rev Camb Philos Socsvezak 81 (broj 3): str. 369.–382.. DOI:10.1017/S1464793106007020. PMID16672105.
Bonah C (2005). „The 'experimental stable' of the BCG vaccine: safety, efficacy, proof, and standards, 1921–1933”. Stud Hist Philos Biol Biomed Scisvezak 36 (broj 4): str. 696.–721.. DOI:10.1016/j.shpsc.2005.09.003. PMID16337557.
Comstock G (1994). „The International Tuberculosis Campaign: a pioneering venture in mass vaccination and research”. Clin Infect Dissvezak 19 (broj 3): str. 528.–540.. DOI:10.1093/clinids/19.3.528. PMID7811874.
Martín Montañés, C; Gicquel, B (2011). „New tuberculosis vaccines.”. Enfermedades infecciosas y microbiologia clinica29 Suppl 1: 57–62. DOI:10.1016/S0213-005X(11)70019-2. PMID21420568.
Ibanga H, Brookes R, Hill P, Owiafe P, Fletcher H, Lienhardt C, Hill A, Adegbola R, McShane H (2006). „Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design”. Lancet Infect Dissvezak 6 (broj 8): str. 522.–528.. DOI:10.1016/S1473-3099(06)70552-7. PMID16870530.
Kaufmann SH (2010). „Future vaccination strategies against tuberculosis: Thinking outside the box”. Immunitysvezak 33 (broj 4): str. 567.–577.. DOI:10.1016/j.immuni.2010.09.015. PMID21029966.
Warrell, ed. by D. J. Weatherall ... [4. + 5. ed.] ed. by David A. (2005). Sections 1 - 10. (4. izdanje izd.). Oxford [u.a.]: Oxford Univ. Press. str. 560. ISBN978-0-19-857014-1.
Jong, [edited by] Jane N. Zuckerman, Elaine C. (2010). Travelers' vaccines (2. izdanje izd.). Shelton, CT: People's Medical Pub. House. str. str. 319.. ISBN978-1-60795-045-5.
Madison B (2001). „Application of stains in clinical microbiology”. Biotech Histochemsvezak 76 (broj 3): str. 119.–125.. DOI:10.1080/714028138. PMID11475314.
Parish T, Stoker N (1999). „Mycobacteria: bugs and bugbears (two steps forward and one step back)”. Molecular Biotechnologysvezak 13 (broj 3): str. 191.–200.. DOI:10.1385/MB:13:3:191. PMID10934532.
van Soolingen D i dr.. (1997). „A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa”. International Journal of Systematic Bacteriologysvezak 47 (broj 4): str. 1236.–1245.. DOI:10.1099/00207713-47-4-1236. PMID9336935.
Thoen C, Lobue P, de Kantor I (2006). „The importance ofMycobacterium bovis as a zoonosis”. Vet. Microbiol.svezak 112 (broj 2–4): str. 339.–345.. DOI:10.1016/j.vetmic.2005.11.047. PMID16387455.
Pfyffer, GE; Auckenthaler, R, van Embden, JD, van Soolingen, D (1998). „Mycobacterium canettii, the smooth variant of M. tuberculosis, isolated from a Swiss patient exposed in Africa.”. Emerging infectious diseasessvezak 4 (broj 4): str. 631.-634.. PMID9866740.
Panteix, G; Gutierrez, MC, Boschiroli, ML, Rouviere, M, Plaidy, A, Pressac, D, Porcheret, H, Chyderiotis, G, Ponsada, M, Van Oortegem, K, Salloum, S, Cabuzel, S, Bañuls, AL, Van de Perre, P, Godreuil, S (2010). „Pulmonary tuberculosis due to Mycobacterium microti: a study of six recent cases in France.”. Journal of medical microbiologysvezak 59 (broj 8): str. 984.-989.. PMID20488936.
American Thoracic Society (1997). „Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association”. Am J Respir Crit Care Medsvezak 156 (broj2 drugi dio): str. S1.–S25.. PMID9279284.
Chaisson, RE; Martinson, NA (2008-03-13). „Tuberculosis in Africa--combating an HIV-driven crisis”. The New England Journal of Medicinesvezak 358 (11): str. 1089.–1092.. DOI:10.1056/NEJMp0800809. PMID18337598.
Griffith D, Kerr C (1996). „Tuberculosis: disease of the past, disease of the present”. J Perianesth Nurssvezak 11 (broj 4): str. 240.–245.. DOI:10.1016/S1089-9472(96)80023-2. PMID8964016.
van Zyl Smit, RN; Pai, M, Yew, WW, Leung, CC, Zumla, A, Bateman, ED, Dheda, K (2010). „Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD.”. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiologysvezak 35 (broj 1): str. 27.-33.. PMID20044459. »These analyses indicate that smokers are almost twice as likely to be infected with TB and to progress to active disease (RR of ∼1.5 for latent TB infection (LTBI) and RR of ∼2.0 for TB disease). Smokers are also twice as likely to die from TB (RR of ∼2.0 for TB mortality), but data are difficult to interpret because of heterogeneity in the results across studies.«
Möller, M; Hoal, EG (2010). „Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis”. Tuberculosis (Edinburgh, Scotland)svezak 90 (broj 2): str. 71.–83.. DOI:10.1016/j.tube.2010.02.002. PMID20206579.
Cole E, Cook C (1998). „Characterization of infectious aerosols in health care facilities: an aid to effective engineering controls and preventive strategies”. Am J Infect Controlsvezak 26 (broj 4): str. 453.–464.. DOI:10.1016/S0196-6553(98)70046-X. PMID9721404.
Nicas M, Nazaroff WW, Hubbard A (2005). „Toward understanding the risk of secondary airborne infection: emission of respirable pathogens”. J Occup Environ Hygsvezak 2 (broj 3): str. 143.–154.. DOI:10.1080/15459620590918466. PMID15764538.
Ahmed N, Hasnain S (2011). „Molecular epidemiology of tuberculosis in India: Moving forward with a systems biology approach”. Tuberculosissvezak 91 (broj 5): str. 407.–413.. DOI:10.1016/j.tube.2011.03.006. PMID21514230.
Houben E, Nguyen L, Pieters J (2006). „Interaction of pathogenic mycobacteria with the host immune system”. Curr Opin Microbiolsvezak 9 (broj 1): 76–85. DOI:10.1016/j.mib.2005.12.014. PMID16406837.
Herrmann J, Lagrange P (2005). „Dendritic cells and Mycobacterium tuberculosis: which is the Trojan horse?”. Pathol Biol (Paris)svezak 53 (broj 1): str. 35.–40.. DOI:10.1016/j.patbio.2004.01.004. PMID15620608.
Jacob, JT; Mehta, AK, Leonard, MK (2009). „Acute forms of tuberculosis in adults.”. The American journal of medicinesvezak 122 (broj 1): str. 12.-17.. PMID19114163.
Bento, J; Silva, AS, Rodrigues, F, Duarte, R (2011). „[Diagnostic tools in tuberculosis].”. Acta medica portuguesasvezak 24 (broj 1): str. 145.–154.. PMID21672452.
Escalante, P (2009-06-02). „In the clinic. Tuberculosis.”. Annals of internal medicinesvezak 150 (broj 11): str. ITC61.-614.; quiz ITV616. PMID19487708.
Metcalfe, JZ; Everett, CK, Steingart, KR, Cattamanchi, A, Huang, L, Hopewell, PC, Pai, M (2011-11-15). „Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis.”. The Journal of infectious diseasessvezak 204 dodatak 4: str. S1120.-S1129.. PMID21996694.
Sester, M; Sotgiu, G, Lange, C, Giehl, C, Girardi, E, Migliori, GB, Bossink, A, Dheda, K, Diel, R, Dominguez, J, Lipman, M, Nemeth, J, Ravn, P, Winkler, S, Huitric, E, Sandgren, A, Manissero, D (2011). „Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis.”. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiologysvezak 37 (broj 1): str. 100.-111.. PMID20847080.
Chen, J; Zhang, R, Wang, J, Liu, L, Zheng, Y, Shen, Y, Qi, T, Lu, H (2011). „Interferon-gamma release assays for the diagnosis of active tuberculosis in HIV-infected patients: a systematic review and meta-analysis.”. PloS onesvezak 6 (broj 11): str. e26827.. PMID22069472.
Rothel J, Andersen P (2005). „Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent?”. Expert Rev Anti Infect Thersvezak 3 (broj 6): str. 981.–993.. DOI:10.1586/14787210.3.6.981. PMID16307510.
Amicosante, M; Ciccozzi, M, Markova, R (2010). „Rational use of immunodiagnostic tools for tuberculosis infection: guidelines and cost effectiveness studies.”. The new microbiologicasvezak 33 (broj 2): str. 93.-107.. PMID20518271.
Menzies, D; Al Jahdali, H, Al Otaibi, B (2011). „Recent developments in treatment of latent tuberculosis infection.”. The Indian journal of medical researchsvezak 133: str. 257.-266.. PMID21441678.
Volmink J, Garner P (2007). „Directly observed therapy for treating tuberculosis”. Cochrane Database Syst Rev (broj 4): str. CD003343.. DOI:10.1002/14651858.CD003343.pub3. PMID17943789.
Liu, Q; Abba, K; Alejandria, MM; Balanag, VM; Berba, RP; Lansang, MA (2008-09-08). „Reminder systems and late patient tracers in the diagnosis and management of tuberculosis.”. Cochrane database of systematic reviews (Online) (broj 4): str. CD006594.. PMID18843723.
O'Brien R (1994). „Drug-resistant tuberculosis: etiology, management and prevention”. Semin Respir Infectsvezak 9 (broj 2): str. 104.–112.. PMID7973169.
Wang, JY; Lee, LN, Lai, HC, Hsu, HL, Liaw, YS, Hsueh, PR, Yang, PC (2007-06-15). „Prediction of the tuberculosis reinfection proportion from the local incidence”. The Journal of infectious diseasessvezak 196 (broj 2): str. 281.–288.. DOI:10.1086/518898. PMID17570116.
FitzGerald, JM; Wang, L, Elwood, RK (2000-02-08). „Tuberculosis: 13. Control of the disease among aboriginal people in Canada.”. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadiennesvezak 162 (broj 3): str. 351.-355.. PMID10693593.
Pearce-Duvet J (2006). „The origin of human pathogens: evaluating the role of agriculture and domestic animals in the evolution of human disease”. Biol Rev Camb Philos Socsvezak 81 (broj 3): str. 369.–382.. DOI:10.1017/S1464793106007020. PMID16672105.
Comas, I; Gagneux, S (2009). „The past and future of tuberculosis research.”. PLoS pathogenssvezak 5 (broj 10): e1000600. PMID19855821.
Bonah C (2005). „The 'experimental stable' of the BCG vaccine: safety, efficacy, proof, and standards, 1921–1933”. Stud Hist Philos Biol Biomed Scisvezak 36 (broj 4): str. 696.–721.. DOI:10.1016/j.shpsc.2005.09.003. PMID16337557.
Comstock G (1994). „The International Tuberculosis Campaign: a pioneering venture in mass vaccination and research”. Clin Infect Dissvezak 19 (broj 3): str. 528.–540.. DOI:10.1093/clinids/19.3.528. PMID7811874.
Lawn, SD; Nicol, MP (2011). „Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance.”. Future microbiologysvezak 6 (broj 9): str. 1067.-1082.. PMID21958145.
Amdekar, Y (2009). „Changes in the management of tuberculosis.”. Indian journal of pediatricssvezak 76 (broj 7): str. 739.-742.. PMID19693453.
Martín Montañés, C; Gicquel, B (2011). „New tuberculosis vaccines.”. Enfermedades infecciosas y microbiologia clinica29 Suppl 1: 57–62. DOI:10.1016/S0213-005X(11)70019-2. PMID21420568.
Ibanga H, Brookes R, Hill P, Owiafe P, Fletcher H, Lienhardt C, Hill A, Adegbola R, McShane H (2006). „Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design”. Lancet Infect Dissvezak 6 (broj 8): str. 522.–528.. DOI:10.1016/S1473-3099(06)70552-7. PMID16870530.
Kaufmann SH (2010). „Future vaccination strategies against tuberculosis: Thinking outside the box”. Immunitysvezak 33 (broj 4): str. 567.–577.. DOI:10.1016/j.immuni.2010.09.015. PMID21029966.
Shivaprasad, HL; Palmieri, C (2012). „Pathology of mycobacteriosis in birds.”. The veterinary clinics of North America. Exotic animal practicesvezak 15 (broj 1): str. 41.-55., v-vi. PMID22244112.
Reavill, DR; Schmidt, RE (2012). „Mycobacterial lesions in fish, amphibians, reptiles, rodents, lagomorphs, and ferrets with reference to animal models.”. The veterinary clinics of North America. Exotic animal practicesvezak 15 (broj 1): str. 25.-40., v. PMID22244111.
Mitchell, MA (2012). „Mycobacterial infections in reptiles.”. The veterinary clinics of North America. Exotic animal practicesvezak 15 (broj 1): str. 101.-111., vii. PMID22244116.
Ryan, TJ; Livingstone, PG, Ramsey, DS, de Lisle, GW, Nugent, G, Collins, DM, Buddle, BM (2006-02-25). „Advances in understanding disease epidemiology and implications for control and eradication of tuberculosis in livestock: the experience from New Zealand.”. Veterinary microbiologysvezak 112 (broj 2.-4.): str. 211.-219.. PMID16330161.
White, PC; Böhm, M, Marion, G, Hutchings, MR (2008). „Control of bovine tuberculosis in British livestock: there is no 'silver bullet'.”. Trends in microbiologysvezak 16 (broj 9): str. 420.-427.. PMID18706814.
Ward, AI; Judge, J, Delahay, RJ (2010-01-01). „Farm husbandry and badger behaviour: opportunities to manage badger to cattle transmission of Mycobacterium bovis?”. Preventive veterinary medicinesvezak 93 (broj 1): str. 2.-10.. PMID19846226.
Southwick F (10. prosinca 2007.). „poglavlje 4: Pulmonary Infections”. Infectious Diseases: A Clinical Short Course, 2. izdanje. McGraw-Hill Medical Publishing Division. str. str. 104.. ISBN0-07-147722-5. Arhivirano iz originala na datum 2012-07-13. Pristupljeno 2013-08-11.
World Health Organization (2009.). „Epidemiology”. Global tuberculosis control: epidemiology, strategy, financing. str. str. 6.–33.. ISBN978-92-4-156380-2. Pristupljeno 12. studenog 2009.[mrtav link]